XB-ART-59469
Mol Psychiatry
2022 Feb 16;282:668-697. doi: 10.1038/s41380-022-01852-9.
Show Gene links
Show Anatomy links
Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition.
Palmer EE
,
Pusch M
,
Picollo A
,
Forwood C
,
Nguyen MH
,
Suckow V
,
Gibbons J
,
Hoff A
,
Sigfrid L
,
Megarbane A
,
Nizon M
,
Cogné B
,
Beneteau C
,
Alkuraya FS
,
Chedrawi A
,
Hashem MO
,
Stamberger H
,
Weckhuysen S
,
Vanlander A
,
Ceulemans B
,
Rajagopalan S
,
Nunn K
,
Arpin S
,
Raynaud M
,
Motter CS
,
Ward-Melver C
,
Janssens K
,
Meuwissen M
,
Beysen D
,
Dikow N
,
Grimmel M
,
Haack TB
,
Clement E
,
McTague A
,
Hunt D
,
Townshend S
,
Ward M
,
Richards LJ
,
Simons C
,
Costain G
,
Dupuis L
,
Mendoza-Londono R
,
Dudding-Byth T
,
Boyle J
,
Saunders C
,
Fleming E
,
El Chehadeh S
,
Spitz MA
,
Piton A
,
Gerard B
,
Abi Warde MT
,
Rea G
,
McKenna C
,
Douzgou S
,
Banka S
,
Akman C
,
Bain JM
,
Sands TT
,
Wilson GN
,
Silvertooth EJ
,
Miller L
,
Lederer D
,
Sachdev R
,
Macintosh R
,
Monestier O
,
Karadurmus D
,
Collins F
,
Carter M
,
Rohena L
,
Willemsen MH
,
Ockeloen CW
,
Pfundt R
,
Kroft SD
,
Field M
,
Laranjeira FER
,
Fortuna AM
,
Soares AR
,
Michaud V
,
Naudion S
,
Golla S
,
Weaver DD
,
Bird LM
,
Friedman J
,
Clowes V
,
Joss S
,
Pölsler L
,
Campeau PM
,
Blazo M
,
Bijlsma EK
,
Rosenfeld JA
,
Beetz C
,
Powis Z
,
McWalter K
,
Brandt T
,
Torti E
,
Mathot M
,
Mohammad SS
,
Armstrong R
,
Kalscheuer VM
.
???displayArticle.abstract???
Missense and truncating variants in the X-chromosome-linked CLCN4 gene, resulting in reduced or complete loss-of-function (LOF) of the encoded chloride/proton exchanger ClC-4, were recently demonstrated to cause a neurocognitive phenotype in both males and females. Through international clinical matchmaking and interrogation of public variant databases we assembled a database of 90 rare CLCN4 missense variants in 90 families: 41 unique and 18 recurrent variants in 49 families. For 43 families, including 22 males and 33 females, we collated detailed clinical and segregation data. To confirm causality of variants and to obtain insight into disease mechanisms, we investigated the effect on electrophysiological properties of 59 of the variants in Xenopus oocytes using extended voltage and pH ranges. Detailed analyses revealed new pathophysiological mechanisms: 25% (15/59) of variants demonstrated LOF, characterized by a "shift" of the voltage-dependent activation to more positive voltages, and nine variants resulted in a toxic gain-of-function, associated with a disrupted gate allowing inward transport at negative voltages. Functional results were not always in line with in silico pathogenicity scores, highlighting the complexity of pathogenicity assessment for accurate genetic counselling. The complex neurocognitive and psychiatric manifestations of this condition, and hitherto under-recognized impacts on growth, gastrointestinal function, and motor control are discussed. Including published cases, we summarize features in 122 individuals from 67 families with CLCN4-related neurodevelopmental condition and suggest future research directions with the aim of improving the integrated care for individuals with this diagnosis.
???displayArticle.pubmedLink??? 36385166
???displayArticle.pmcLink??? PMC9908558
???displayArticle.link??? Mol Psychiatry
???displayArticle.grants??? [+]
Species referenced: Xenopus laevis
Genes referenced: clcn4
GO keywords: X chromosome [+]
???displayArticle.disOnts??? neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies
???attribute.lit??? ???displayArticles.show???
![]() |
Fig. 1: Pedigrees of all previously unreported families with inherited CLCN4 variants. Filled square/circle = affected individual, lightly shaded circle/square = mildly affected individual, *familial *CLCN4 variant present in affected males, − familial CLCN4 variant absent in male, */− familial CLCN4 variant present in female, −/− familial CLCN4 variant absent in female. Pedigrees of families with a de novo variant are not shown. |
![]() |
Fig. 2: Clinical photographs of individuals with previously unreported variants in CLCN4, and representative neuroimaging. A Clinical photographs demonstrate that some males and females have progressive lengthening of their face and ‘squaring’ of the jaw with age. LOF loss-of-function, GOF gain-of-function, ROF reduction of function, m months, y years. B Neuroimaging (T1 mid-sagittal view) from affected probands. In all individuals there are abnormalities of the corpus callosum. The proband of Family A10 has a dysplastic corpus callosum: it is of normal length but globally hypoplastic. Family A19: two affected brothers both display complete agenesis of the corpus callosum with colpocephaly. Family B5: the proband has partial agenesis of the corpus callosum (affecting the posterior part and splenium), colpocephaly and mild dilatation of the 3rd ventricle. Family B6: the proband has a dysplastic corpus callosum, and mildly small optic chiasm and optic nerves bilaterally. |
![]() |
Fig. 3: Mapping of all CLCN4 variants functionally investigated in this study. A Schematic of the CLCN4 gene and ClC4-protein with position of variants from newly identified families with clearly affected males and females depicted above the schematic, and position of variants published to date shown below the schematic. B Position of the investigated missense variants in a CLC topology model. Altered residues are shown as circles and functional effects are color-coded as indicated in the figure. C Three-dimensional homology model of the human ClC-4 protein based on the structure of the CmClC homodimer (Protein Data Bank: 3ORG). The view from within the membrane delimited by dashed lines. The two subunits forming the homodimer are shown in dark and light grey. Mutated residues are shown as spheres colored as in B. Right 3D model viewed from the extracellular site. |
![]() |
Fig. 4: Expression of CLCN4 variants in Xenopus oocytes. Panel A shows example recordings of the indicated constructs evoked by the voltage-clamp protocol indicated in the inset and using a “P/4” leak subtraction protocol (see Methods). Scale bars apply to all constructs. B shows average normalized IV relationships of the same variants. Currents are normalized to that of WT at 170 mV as described in Methods. In C, currents are normalized to the current of WT at the same voltage (see Methods). Data points are significantly different at practically all voltages from the value of 1 (i.e., WT) for all indicated variants (p < 0.05). Panel D shows typical current traces recorded without leak subtraction of WT ClC-4 in the presence of neutral and acidic extracellular pH, with outward currents being inhibited and inward currents remaining at a negligible level [29]. E illustrates the pH response of variant p.(Ile549Asn), which shows the activation of relatively large inward currents at acidic pH. F, G quantitative analysis of pH dependence of indicated GOF variants. Currents recorded at pH 5.3 were normalized to values measured at pH 7.3 as described in methods. The GOF effect of variants p.(Val317Ile) and p.(Ser395Arg) becomes apparent in panel G that shows the same data as panel F at a magnified scale. Data points are significantly different at voltages <= −40 mV from WT for all indicated variants (p < 0.05). Panel H shows differences in reversal potential measured at pH 6.3 and pH 5.3 for variants p.(Phe268Leu) and p.(Ile549Asn). The red line indicates the value expected for a stoichiometrically coupled 2 Cl−/1 H+ antiporter. |
References [+] :
Accardi,
Secondary active transport mediated by a prokaryotic homologue of ClC Cl- channels.
2004, Pubmed
Accardi, Secondary active transport mediated by a prokaryotic homologue of ClC Cl- channels. 2004, Pubmed
Adam, NULL 1993, Pubmed
Banerjee-Basu, SFARI Gene: an evolving database for the autism research community. 2010, Pubmed
Claes, Regional localization of two genes for nonspecific X-linked mental retardation to Xp22.3-p22.2 (MRX49) and Xp11.3-p11.21 (MRX50). 1997, Pubmed
De Stefano, A single point mutation reveals gating of the human ClC-5 Cl-/H+ antiporter. 2013, Pubmed , Xenbase
Dingemans, Human disease genes website series: An international, open and dynamic library for up-to-date clinical information. 2021, Pubmed
Drossman, Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. 2016, Pubmed
Duncan, Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders. 2021, Pubmed , Xenbase
Firth, DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. 2009, Pubmed
Fokkema, LOVD v.2.0: the next generation in gene variant databases. 2011, Pubmed
Friedrich, Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents. 1999, Pubmed , Xenbase
Guo, Whole-Exome Sequencing for Identifying Genetic Causes of Intellectual Developmental Disorders. 2021, Pubmed
Guzman, Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments. 2017, Pubmed
He, The molecular and phenotypic spectrum of CLCN4-related epilepsy. 2021, Pubmed
Hu, X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes. 2016, Pubmed
Jentsch, CLC Chloride Channels and Transporters: Structure, Function, Physiology, and Disease. 2018, Pubmed
Kasper, Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. 2005, Pubmed
Klee, Impact of integrated translational research on clinical exome sequencing. 2021, Pubmed
Landrum, ClinVar at five years: Delivering on the promise. 2018, Pubmed
Leisle, ClC-7 is a slowly voltage-gated 2Cl(-)/1H(+)-exchanger and requires Ostm1 for transport activity. 2011, Pubmed
Lorenz, Heteromultimeric CLC chloride channels with novel properties. 1996, Pubmed , Xenbase
Ludwig, Common gating of both CLC transporter subunits underlies voltage-dependent activation of the 2Cl-/1H+ exchanger ClC-7/Ostm1. 2013, Pubmed , Xenbase
Menke, Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics. 2021, Pubmed
Mossink, Human neuronal networks on micro-electrode arrays are a highly robust tool to study disease-specific genotype-phenotype correlations in vitro. 2021, Pubmed
Palmer, A contravention of Ohno's law in mice. 1995, Pubmed
Palmer, Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies. 2021, Pubmed
Palmer, Dissecting the clinical outcome and cause of abnormalities of the corpus callosum. 2016, Pubmed
Palmer, Agenesis of the corpus callosum: a clinical approach to diagnosis. 2014, Pubmed
Palmer, De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females. 2018, Pubmed , Xenbase
Picollo, Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. 2005, Pubmed
Poët, Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6. 2006, Pubmed
Polovitskaya, A Recurrent Gain-of-Function Mutation in CLCN6, Encoding the ClC-6 Cl-/H+-Exchanger, Causes Early-Onset Neurodegeneration. 2020, Pubmed
Posey, Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation. 2017, Pubmed
Raynaud, X-linked mental retardation with neonatal hypotonia in a French family (MRX15): gene assignment to Xp11.22-Xp21.1. 1996, Pubmed
Richards, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. 2015, Pubmed
Rickheit, Role of ClC-5 in renal endocytosis is unique among ClC exchangers and does not require PY-motif-dependent ubiquitylation. 2010, Pubmed
Stobrawa, Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. 2001, Pubmed
Traverso, Proton sensing of CLC-0 mutant E166D. 2006, Pubmed , Xenbase
Veeramah, Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. 2013, Pubmed , Xenbase
Weinert, Uncoupling endosomal CLC chloride/proton exchange causes severe neurodegeneration. 2020, Pubmed
Xu, Novel CLCN4 variant associated with syndromic X-linked intellectual disability in a Chinese girl: a case report. 2021, Pubmed
Zhou, Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies. 2018, Pubmed
Zifarelli, Altered voltage-dependence of slowly activating chloride-proton antiport by late endosomal ClC-6 explains distinct neurological disorders. 2022, Pubmed